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Abstract
The World Health Organization’s (WHO’s) World Health Report 2010, “Health systems financing, the path to 
universal coverage,” promoted universal health coverage (UHC) as an aspirational objective for country health 
systems. Yet, in addition to the dimensions of services and coverage, distribution of coverage in the population, 
and financial risk protection highlighted by the report, the consideration of the budget constraint should be 
further strengthened in the ensuing debate on resource allocation toward UHC. Beyond the substantial financial 
constraints faced by low- and middle-income countries, additional considerations, such as the geographical 
context, the underlying country infrastructure, and the architecture of health systems, determine the feasibility, 
effectiveness, quality and cost of healthcare delivery. Therefore, increased production and use of local evidence 
tied to the criteria of health benefits, equity, financial risk protection, and costs accompanying health delivery 
are needed so that to highlight pathways and acceptable trade-offs toward UHC.
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The World Health Organization’s (WHO’s) World Health Report 2010, “Health systems financing, the path to universal coverage,”1 proposed universal 
health coverage (UHC) as an aspirational objective for 
countries’ health sector to rally around. In particular, using 
the metaphor of a cube, later coined as “the WHO cube,” the 
report highlighted three important dimensions for health 
systems to consider on the path toward UHC: (i) which health 
services should be covered; (ii) which populations should 
be covered; and (iii) what share of the direct health services 
costs should be financed by the public sector, public finance, 
and prepayment mechanisms (eg, social health insurance) 
vs. from out-of-pocket (OOP) expenditures financed by 
individuals and households. This third dimension directly 
relates to one of the fundamental intents of health systems 
which is tied to financial risk protection and the prevention 
of medical impoverishment.
The theme of UHC was recently included in the Sustainable 
Development Goals (SDGs) which were ratified by the United 
Nations General Assembly in New York in September 2015. 
Specifically, the third goal (SDG3), dedicated to health, “to 
ensure healthy lives and promote well-being for all at all ages,” 
includes a subtarget on achieving “UHC, including financial 
risk protection and access to quality, essential health services.”2 
Furthermore, the first goal (SDG1) endorses the objective 
“to end poverty in all its forms everywhere” by 2030, where 
financial risk protection in health can play a crucial role.
Yet, in both the debate on the practical implications of UHC 
and the discourse of the SDGs, there is limited emphasis 
on the “budget constraint.” In other words, we find little 
discussion of the fact that these grand objectives would have 
to be fulfilled with highly restricted financial resources, and 
that therefore, difficult choices and politically sensitive trade-
offs, such as the ones described by Norheim,3 would have to 
be examined.
With five case studies, Norheim3 forcefully illustrates some 
of the difficult real-world situations which may be faced 
by policy-makers on the way to UHC. Even before ethical 
considerations are addressed, his descriptions fundamentally 
point us to the critical importance of the budget constraint, an 
essential element for decision-makers in charge of allocating 
resources on the way toward UHC. That is to say, a decision-
maker should consider the following three dimensions in 
examining pathways toward UHC: (1) which services should 
be covered? (eg, interventions addressing non-communicable 
diseases vs. interventions tackling infectious diseases and 
maternal conditions); (2) which populations should be 
covered? (eg, rural vs. urban populations); (3) which costs 
should be financed by the public sector, through prepayment 
mechanisms or by direct OOP payments? (eg, which services 
should be exempted? what should be the size of the copayment 
for some services?). And all three dimensions ought to be 
considered within a certain budget, in other words they are 
constrained by the overall size of public financing dedicated 
to health.
Therefore, from the perspective of the analyst, the move 
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toward UHC may be best regarded as the evolution within a 
three-dimensional space given multiple constraints including 
the budget constraint. Using this schematic, the three-
dimensional space can be defined along the three axes of 
services (x-axis), population coverage (y-axis), within which 
falls the issues of distributions and equity, and size of direct 
OOP payments (z-axis), within which falls the issues of 
financial risk protection and poverty reduction. Meanwhile, 
the allocation of financial resources along these three axes 
will be constrained by the disposable budget. Evidently, there 
exists an infinite number of directions to which one could 
move in this three-dimensional space; and, consequently, 
there is an infinite number of pathways which countries could 
take toward UHC. Nonetheless, critical judgments, whether 
inferred from an economic, ethical or political standpoint, 
will impose certain directions as opposed to others, within 
this three-dimensional space. For instance, Norheim3 utilizes 
his ethical appreciation and thus forbids certain pathways 
as he reflects on what would be unacceptable trade-offs in 
his opinion. Norheim explicitly imposes restrictions on the 
directions on the move toward UHC with respect to the axes 
of services, population coverage, and direct OOP payments. 
In particular, his unacceptable trade-offs are materialized 
by specific regions within the three-dimensional space 
where multiple constraints, including budget, operate. These 
discrete regions are for example delimited by distributions (eg, 
rural vs. urban populations) along the population coverage 
axis, or the categorization of high, medium, and low priority 
interventions along the services axis.
Importantly, careful thinking as how to move coincidentally 
along these three dimensions/axes should be given as countries 
attempt to fulfill UHC, and especially take into account the 
prior construction and idiosyncrasies of local health systems, 
the rapid changes in epidemiological profiles, and the fast 
urbanization of countries. Specifically, countries are facing 
a variety of constraints. First, there are important health 
system constraints: for example, a lack of health workforce 
and a sparse and uneven distribution of health facilities may 
prevent the delivery of key interventions including those 
ordinarily deemed most cost-effective. The scale-up of such 
interventions would require substantial investments in the 
redesign of the health system and hence would be prohibitively 
expensive. Second, there are contextual constraints: for 
instance, countries’ infrastructure, such as the presence or the 
absence of a good network of roads and transportation means, 
is determinant for delivery and access to quality healthcare. 
As a result, due to a lack of good infrastructure, the marginal 
costs of healthcare delivery may become very large, or the 
health services provided might face quality issues and be 
ineffective (eg, vaccine cold chain being broken leading to 
reduced vaccine efficacy). On the other hand, some specific 
subpopulations (eg, the hard-to-reach and the poorest) may 
be facing a larger burden of disease and be most at need: 
for example, individuals in the poorest income quintile 
may be at a higher risk of infection from severe infectious 
diseases (eg, tuberculosis). Therefore, some of the trade-offs 
highlighted by Norheim might be impacted by the inclusion 
of some of these realities, pointing to the critical importance 
of local evidence for informed decision-making. Beyond, the 
selection of pathways toward UHC will be greatly influenced 
by the underlying political and social forces. For example, 
pressures from the clinical sector, political constituencies, 
and the civil society may push for curative as opposed to 
preventive services.4 Likewise, a pro-rich bias toward the use 
of expensive treatments may be observed in many countries 
highlighting the influence of elites on the decision-making 
process5; and the development of universal public finance for 
healthcare delivery targeting specific segments of populations 
might be confronted with the rapid expansion of the private 
sector in low- and middle-income countries.6 
Multiple criteria are to be examined when moving toward 
UHC, some of which were well-described in WHO’s report 
on “Making fair choices on the path to UHC.”7 Clear 
definitions about the criteria to be considered, complemented 
by tailored economic evaluation methods, such as “extended 
cost-effectiveness analysis,”8,9 which examine the impact of 
policy in multiple outcome dimensions (eg, health gains, 
distributional consequences, financial risk protection) per 
budget constraint, are needed.
Moreover, we require clear definitions and consensus about 
the meanings of “high priority services,” “medium priority 
services,” and “low priority services” so to enact transparent 
decision rules. Hence, similarly to epidemiologic information 
on the burden of disease, further investigation toward 
collecting systematic evidence on the financial burden of 
disease faced by households and families is urgent, so that 
health systems could also deliver “financial risk protection 
cost-effective” services.9 For example, one publicly financed 
service might provide high financial protection to a country’s 
citizens because it is costly, whereas another intervention 
might provide similar levels of financial protection because 
it is cheap and prevents repeated moderately costly events 
(eg, malaria episodes). As a case in point, recent qualitative 
work by Miljeteig and colleagues (I. Miljeteig, A. Melkie, 
F. Berhane, E. Dessie, K.H. Onarheim, unpublished data) 
who interviewed both patients and providers in rural areas 
of Ethiopia demonstrated that the financial protection 
considerations were essential in the ultimate decisions taken 
by patients and providers in cases of both serious clinical 
and poverty consequences. Importantly, financial protection 
considerations should not be conceived under the lens of 
direct medical payments only, but also comprehensively add 
the aspects of transportation costs and indirect costs including 
time losses and wages foregone due to the onset of disease.
As a result, policy-makers will always be confronted with 
trade-offs, such as the five unacceptable trade-offs which 
Norheim emphasizes, especially so on the way toward UHC. 
These five illustrations demonstrate the challenges ahead 
for countries who need a more contextualized evidence base 
before embarking on systematic decisions. The resulting 
informed priority setting process should involve the patients, 
the decision-makers, the public and the society as a whole. 
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